Ann Arbor, MI, United States of America

Toshihide Iwashita

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of Michigan. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihide Iwashita. Retrieved from https://idiyas.com/inventor/toshihide-iwashita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Toshihide Iwashita in Hematopoietic Stem Cell Research

Introduction

Toshihide Iwashita is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of hematopoietic stem cell research. With a total of 3 patents, his work focuses on the identification and isolation of hematopoietic stem cells (HSCs).

Latest Patents

Iwashita's latest patents include innovative methods for identifying, collecting, and isolating hematopoietic stem cells. His inventions specifically provide methods for isolating and purifying CD150HSCs, CD48HSCs, and CD244HSCs. Additionally, these patents relate to purified cell samples enriched with these specific HSC populations, along with methods for treating subjects using such compositions.

Career Highlights

Toshihide Iwashita is affiliated with the University of Michigan, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Iwashita has collaborated with notable colleagues, including Mark J Kiel and Sean J Morrison, further enhancing the impact of his research.

Conclusion

Toshihide Iwashita's contributions to hematopoietic stem cell research exemplify the importance of innovation in medical science. His patents and ongoing work continue to pave the way for advancements in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…